ArticleCancer research2026
Interplay of Glioblastoma Cells with Microglia Shapes Invasive Phenotypes during Long-distance Invasion.
Article in Cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reconstructing the glioblastoma microenvironment in heterotypic 3D spheroids: a multicellular model to study tumor-stromal crosstalk.Frontiers in bioengineering and biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Glioblastoma (GBM) infiltration poses a formidable therapeutic challenge, but the mechanisms enabling long-distance tumor invasion remain poorly defined. In a recent study, Nebeling and colleagues have leveraged longitudinal three-photon intravital microscopy to visualize the migratory behavior of invading GBM cells and their interactions with microglia. Using an immunocompetent autochthonous murine GBM model for live imaging of the contralateral cortex and corpus callosum (CC), the team demonstrated that the migration velocity of GBM cells varied by anatomic location, with tumor cells moving faster in the CC than in the cortex. Furthermore, GBM cells with less tumor microtubes (TM) exhibited higher motility and traveled longer distances than TM-rich cells. Interestingly, the authors also uncovered a stage-dependent, biphasic microglial response to invading GBM cells: enhanced surveillance during sparse infiltration, followed by suppressed surveillance as tumor burden increases. Functional analyses identified chemokine receptor CX3CR1 as a key regulator of microglial reactivity and a requirement of microglia to drive GBM invasiveness. These findings align with earlier evidence that spatial constraints and microglial organization influence GBM invasion. Together, these works highlight a critical role of microglia and the tumor microenvironment in shaping invasive GBM phenotypes and offer new avenues for therapeutic strategies to limit GBM invasion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.